True Wealth Design’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
True Wealth Design's TRML Position: Q4 2025 in Review
True Wealth Design sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 18 shares — an estimated $861 sold.
True Wealth Design first reported a position in TRML in Q1 2025 and held it in 3 quarters. The position peaked at $861 in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.
- True Wealth Design reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
- True Wealth Design sold 18 Tourmaline Bio shares in Q4 2025, an estimated $861.
- True Wealth Design first reported a position in Tourmaline Bio in Q1 2025 and held it in 3 quarters.
- True Wealth Design's Tourmaline Bio position peaked at $861 in Q3 2025.
- 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.
Based on True Wealth Design's 13F filing for Q4 2025, filed 8 Jan 2026.